Novel approaches towards pharmacological enhancement of motivation
type: CreativeWork
description: This work explores novel approaches towards pharmacological enhancement of motivated behaviour. A loss of motivation remains a severe unmet clinical need in a number of neuropsychiatric and neurodegenerative disorders. The work described in this thesis, can be divided into two sections. Initially, a series of experiments were conducted that aimed to increase the likelihood of cross-species translation of motivation research. This was achieved by firstly optimising and validating a battery of tasks to assess effort-related behaviour, a preclinical measure of motivation, in rats for use within an operant touchscreen platform. This will allow tasks to be performed with high face validity, across species. Secondly, we applied a highly translatable functional imaging measure, in vivo oxygen amperometry, to explore whether a neural correlate of motivated behaviour could be detected in rats. The second section describes the identification and exploration of a novel pharmacological target for treating apathy. By using a progressive ratio (PR) schedule of reinforcement, muscarinic acetylcholine receptor antagonists were found to facilitate motivated behaviour in intact mice. Furthermore, through the application of several compounds, these actions appeared to be driven by the M1 receptor subtype. Subsequently, nonpathological aging was examined as a potential model of impaired motivation, based upon previous reports. However, the deficit was found not to be reliable. Therefore, the effects of the muscarinic acetylcholine receptor antagonist biperiden was tested following administration of the dopamine receptor antagonist haloperidol, a well-validated model of impaired motivation. Biperiden was able to successfully, reverse the effects of haloperidol on effort-based behaviour. This suggests that the drug biperiden may be a therapeutic option in the treatment of apathy.
abstract: This work explores novel approaches towards pharmacological enhancement of motivated behaviour. A loss of motivation remains a severe unmet clinical need in a number of neuropsychiatric and neurodegenerative disorders. The work described in this thesis, can be divided into two sections. Initially, a series of experiments were conducted that aimed to increase the likelihood of cross-species translation of motivation research. This was achieved by firstly optimising and validating a battery of tasks to assess effort-related behaviour, a preclinical measure of motivation, in rats for use within an operant touchscreen platform. This will allow tasks to be performed with high face validity, across species. Secondly, we applied a highly translatable functional imaging measure, in vivo oxygen amperometry, to explore whether a neural correlate of motivated behaviour could be detected in rats. The second section describes the identification and exploration of a novel pharmacological target for treating apathy. By using a progressive ratio (PR) schedule of reinforcement, muscarinic acetylcholine receptor antagonists were found to facilitate motivated behaviour in intact mice. Furthermore, through the application of several compounds, these actions appeared to be driven by the M1 receptor subtype. Subsequently, nonpathological aging was examined as a potential model of impaired motivation, based upon previous reports. However, the deficit was found not to be reliable. Therefore, the effects of the muscarinic acetylcholine receptor antagonist biperiden was tested following administration of the dopamine receptor antagonist haloperidol, a well-validated model of impaired motivation. Biperiden was able to successfully, reverse the effects of haloperidol on effort-based behaviour. This suggests that the drug biperiden may be a therapeutic option in the treatment of apathy.
author: Hailwood, Jonathan Michael
language: en
keywords: Muscarinic, Motivation, Translational, Touch Screen, Apathy
license: https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/0fe0c67e-cb3c-4f4e-b252-2e9e88a7d45d/download
license: https://www.rioxx.net/licenses/all-rights-reserved/
date published: 2019-06-30
date modified: 2026-07-22T22:24:23Z
provider: Cambridge University
publisher: Networked Digital Library of Theses and Dissertations
type: WebPage
source organization: University of Cambridge

PropertyValue
property ID: DOI
value: 10.17863/CAM.40216